Inventor · disambiguated record
Vidyasagar Vuligonda
Also filed as: VULIGONDA VIDYASAGAR · VULIGONDA VIDYASAGAR PRADEEP
86 granted patents·6 pending applications·3,259 citations·filing 1994–2024
99Inventor score
Files withALLERGAN INC47ALLERGAN SALES INC23IO THERAPEUTICS INC10BEARD RICHARD L4VULIGONDA VIDYASAGAR3
Top patents by PatentIndex Score
92 records- 0197US5877207ASynthesis and use of retinoid compounds having negative hormone and/or antagonist activitiesALLERGAN SALES INC·Filed 1997·Granted Mar 2, 1999·245 cites·34 claims
- 0297US5648514ASubstituted acetylenes having retinoid-like biological activityALLERGAN INC·Filed 1994·Granted Jul 15, 1997·69 cites·16 claims
- 0397US5514825AAcetylenes disubstituted with a 5 substituted tetrahydronaphthyl group and with an aryl or heteroaryl group having retinoid-like biological activityALLERGAN INC·Filed 1994·Granted May 7, 1996·87 cites·17 claims
- 0497US5489584AAcetylenes disubstituted with a 5-amino or substituted 5-amino substituted tetrahydronaphthyl group and with an aryl or heteroaryl group having retinoid-like biological activityALLERGAN INC·Filed 1994·Granted Feb 6, 1996·107 cites·15 claims
- 0596US10590059B2Compounds and synthetic methods for the preparation of retinoid X receptor-specific retinoidsIO THERAPEUTICS INC·Filed 2018·Granted Mar 17, 2020·17 cites·17 claims
- 0696US6555690B2Alkyl or aryl substituted dihydronaphthalene derivatives having retinoid and/or retinoid antagonist-like biological activityALLERGAN INC·Filed 2002·Granted Apr 29, 2003·43 cites·12 claims
- 0796US5958954ASynthesis and use of retinoid compounds having negative hormone and/or antagonist activitiesALLERGAN SALES INC·Filed 1997·Granted Sep 28, 1999·176 cites·46 claims
- 0896US5917082A2,4-pentadienoic acid derivatives having retinoid-like biological activityALLERGAN SALES INC·Filed 1997·Granted Jun 29, 1999·86 cites·3 claims
- 0996US5675033A2,4-pentadienoic acid derivatives having retinoid-like biological activityALLERGAN INC·Filed 1995·Granted Oct 7, 1997·111 cites·14 claims
- 1096US5648503AAcetylenes disubstituted with a 5 substituted tetrahydronaphthyl group and with an aryl or heteroaryl group having retinoid-like biological activityALLERGAN INC·Filed 1996·Granted Jul 15, 1997·78 cites·12 claims
- 1196US5605915AAcetylenes disubstituted with a 5 substituted tetrahydronaphthyl group and with an aryl or heteroaryl group having retinoid-like biological activityALLERGAN INC·Filed 1996·Granted Feb 25, 1997·74 cites·18 claims
- 1296US5599967AAcetylenes disubstituted with a 5 substituted tetrahydronaphthyl group and with an aryl of heteroaryl group having retinoid-like biological activityALLERGAN INC·Filed 1994·Granted Feb 4, 1997·65 cites·16 claims
- 1396US5543534AAcetylenes disubstituted with a 5 substituted tetrahydronaphthyl group and with an aryl or heteroaryl groups having retinoid-like biological activityALLERGAN INC·Filed 1994·Granted Aug 6, 1996·81 cites·23 claims
- 1495US11793835B2Methods of using RARγ agonists for cancer treatmentIO THERAPEUTICS INC·Filed 2022·Granted Oct 24, 2023·1 cites·17 claims
- 1595US6818775B2Alkyl or aryl substituted dihydronaphthalene derivatives having retinoid and/or retinoid antagonist-like biological activityALLERGAN INC·Filed 2003·Granted Nov 16, 2004·36 cites·11 claims
- 1695US6720425B2Alkyl or aryl substituted dihydronaphthalene derivatives having retinoid and/or retinoid antagonist-like biological activityALLERGAN INC·Filed 2002·Granted Apr 13, 2004·36 cites·14 claims
- 1795US6521624B1Synthesis and use of retinoid compounds having negative hormone and/or antagonist activitiesALLERGAN INC·Filed 2000·Granted Feb 18, 2003·39 cites·11 claims
- 1895US6090810ASynthesis and use of retinoid compounds having negative hormone and/or antagonist activitiesALLERGAN SALES INC·Filed 1998·Granted Jul 18, 2000·59 cites·38 claims
- 1995US5952345ASynthesis and use of retinoid compounds having negative hormone and/or antagonist activitiesALLERGAN SALES INC·Filed 1997·Granted Sep 14, 1999·83 cites·31 claims
- 2095US5773594AAlkyl or aryl substituted dihydronaphthalene derivatives having retinoid and/or retinoid antagonist-like biological activityALLERGAN INC·Filed 1996·Granted Jun 30, 1998·67 cites·11 claims
- 2195US5663367A2,4-pentadienoic acid derivatives having retinoid-like biological activityALLERGAN INC·Filed 1996·Granted Sep 2, 1997·95 cites·10 claims
- 2295US5618931AAcetylenes disubstituted with a 5 substituted dihydronaphthyl group and with an aryl or heteroaryl group having retinoid-like biological activityALLERGAN INC·Filed 1994·Granted Apr 8, 1997·67 cites·43 claims
- 2394US6653483B1Alkyl or aryl substituted dihydronaphthalene derivatives having retinoid and/or retinoid antagonist-like biological activityFiled 2000·Granted Nov 25, 2003·36 cites·15 claims
- 2494US6228848B1Synthesis and use of retinoid compounds having negative hormone and/or antagonist activitiesALLERGAN INC·Filed 1999·Granted May 8, 2001·65 cites·14 claims
- 2594US6211385B1Process for preparing substituted benzo[1,2-G]-chrome-3-ene, benzo[1,2-G]-thiochrom-3-ene and benzo[1,2-G]-1,2-dihydroquinoline derivativesALLERGAN SALES INC·Filed 2000·Granted Apr 3, 2001·36 cites·15 claims
- 2694US6008204ASynthesis and use of retinoid compounds having negative hormone and/or antagonist activitiesALLERGAN SALES INC·Filed 1998·Granted Dec 28, 1999·55 cites·10 claims
- 2794US5728846ABenzo 1,2-g!-chrom-3-ene and benzo 1,2-g!-thiochrom-3-ene derivativesALLERGAN INC·Filed 1996·Granted Mar 17, 1998·92 cites·22 claims
- 2893US11919848B2RXR agonist salt form, polymorphs thereof, and uses thereofIO THERAPEUTICS INC·Filed 2023·Granted Mar 5, 2024·1 cites·20 claims
- 2993US8618163B2Derivatives of cycloalkyl- and cycloalkenyl-1,2-dicarboxylic acid compounds having formyl peptide receptor like-1 (FPRL-1) agonist or antagonist activityBEARD RICHARD L·Filed 2011·Granted Dec 31, 2013·7 cites·8 claims
- 3093US8097644B2Indole compounds having sphingosine-1-phosphate (S1P) receptor antagonistBEARD RICHARD L·Filed 2007·Granted Jan 17, 2012·12 cites·7 claims
- 3193US7166726B2Aryl substituted 3,4-dihydroanthracene derivatives having retinoid antagonist or retinoid inverse agonist type biological activityALLERGAN INC·Filed 2003·Granted Jan 23, 2007·36 cites·9 claims
- 3293US6538149B1Aryl or heteroaryl substituted 3,4-dihydroanthracene and aryl or heteroaryl substituted benzo [1,2-g]chrom-3-ene, benzo[1,2-g]-thiochrom-3-ene and benzo [1,2-g]-1,2-dihydroquinoline derivatives having retinoid antagonist or retinoid inverse agonist type biological activityALLERGAN INC·Filed 2000·Granted Mar 25, 2003·41 cites·4 claims
- 3393US6313163B12,4-pentadienoic acid derivatives having retinoid-like biological activityALLERGEN SALES INC·Filed 2000·Granted Nov 6, 2001·43 cites·25 claims
- 3493US5763635ATetrahydronaphthalene derivatives substituted in the 8 position with alkyhidene groups having retinoid and/or retinoid antagonist-like biological activityALLERGAN INC·Filed 1996·Granted Jun 9, 1998·54 cites·36 claims
- 3593US5723666AOxime substituted tetrahydronaphthalene derivatives having retinoid and/or retinoid antagonist-like biological activityALLERGAN INC·Filed 1996·Granted Mar 3, 1998·71 cites·36 claims
- 3693US5654469AAcetylenes disubstituted with a 5 substituted tetrahydronaphthyl group and with an aryl or heteroaryl groups having retinoid-like biological activityALLERGAN INC·Filed 1996·Granted Aug 5, 1997·49 cites·35 claims
- 3793US5618943AAcetylenes disubstituted with a 5 OXO substituted tetrahydronaphthyl group and with an aryl or heteroaryl group having retinoid-like biological activityALLERGAN INC·Filed 1994·Granted Apr 8, 1997·66 cites·32 claims
- 3893US5591858AAcetylenes disubstituted with a 5 substituted tetrahydronaphthyl group and with an aryl or heteroaryl group having retinoid-like biological activityALLERGAN INC·Filed 1996·Granted Jan 7, 1997·61 cites·19 claims
- 3991US6403638B12,4-pentadienoic acid derivatives having selective activity for retinoid X (RXR) receptorsALLERGAN SALES INC·Filed 2000·Granted Jun 11, 2002·45 cites·20 claims
- 4090US6344561B2O- or S- substituted tetrahydronaphthalene derivatives having retinoid and/or retinoid antagonist-like biological activityALLERGAN SALES INC·Filed 2000·Granted Feb 5, 2002·16 cites·15 claims
- 4190US6117987AAlkyl or aryl substituted dihydronaphthalene derivatives having retinoid and/or retinoid antagonist like biological activityALLERGAN SALES INC·Filed 1998·Granted Sep 12, 2000·39 cites·7 claims
- 4290US6114533A2,4-pentadienoic acid derivatives having retinoid-like biological activityALLERGAN SALES INC·Filed 1999·Granted Sep 5, 2000·53 cites·8 claims
- 4390US5998655AAlkylidene substituted tetrahydronaphthalene derivatives having retinoid and/or retinoid antagonist-like biological activityFiled 1998·Granted Dec 7, 1999·38 cites·23 claims
- 4488US8492556B22,5-Dioxoimidazolidin-1-yl-3-phenylurea derivatives as formyl peptide receptor like-1 (FPRL-1) receptor modulatorsALLERGAN INC·Filed 2012·Granted Jul 23, 2013·11 cites·15 claims
- 4588US6048873ATetrahdroquinolin-2-one 6 or 7-yl, tetrahdroquinilin-2-thione 6 or 7-yl pentadienoic acid and related derivatives having retinoid-like biological activityALLERGAN SALES INC·Filed 1998·Granted Apr 11, 2000·79 cites·24 claims
- 4688US6043381AProcess for preparing substituted benzo[1,2-g]-chrom-3-ene, benzo[1,2-g]-thiochrom-3-ene and benzo[1,2-g]-1,2-dihydroquinoline derivativesALLERGAN SALES INC·Filed 1999·Granted Mar 28, 2000·38 cites·22 claims
- 4787US11976021B2Synthesis of tetrahydronaphthalenols and uses thereofIO THERAPEUTICS INC·Filed 2023·Granted May 7, 2024·0 cites·17 claims
- 4887US6034242A2,4-pentadienoic acid derivatives having retinoid-like biological activityALLERGAN SALES INC·Filed 1998·Granted Mar 7, 2000·42 cites·9 claims
- 4987US5817836A2,4-pentadienoic acid derivatives having retinoid-like biological activityALLERGAN INC·Filed 1997·Granted Oct 6, 1998·44 cites·13 claims
- 5086US6720423B2Dihydrobenzofuran and dihydrobenzothiophene 2,4-pentadienoic acid derivatives having selective activity for retinoid X (RXR) receptorsALLERGAN INC·Filed 2002·Granted Apr 13, 2004·41 cites·54 claims
Showing the top 50 of 92 patent records by PatentIndex Score.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →